| 產(chǎn)品名稱 |
Human rhinovirus 95 |
| 商品貨號(hào) |
B162867 |
| Classification |
Picornaviridae, Rhinovirus, Human rhinovirus A |
| Deposited As |
Rhinovirus type 95 |
| Agent |
Human rhinovirus 95 |
| Strain |
SF-998 |
| Applications |
Respiratory research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Upper respiratory tract |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Comments |
Does not cross-react with other recognized rhinoviruses. Grown in HeLa cells orginally contaminated with Mycoplasma orale and then cured. Does not cross-react with other recognized rhinoviruses. Grown in HeLa cells orginally contaminated with Mycoplasma orale and then cured. |
| Effect on Host |
Yes, in vitro effects: Cytopathic effects (destruction of host cells) Typical rhinovirus CPE in cell culture, including rounding and sloughing of infected cells. |
| Recommended Host |
human fibroblasts Host of Choice: Human fibroblasts. HeLa cells (ATCC CCL-2); human fibroblasts |
| Growth Conditions |
Temperature: 33.0°C |
| Name of Depositor |
VV Hamparian |
| Source |
Upper respiratory tract |
| References |
Hamparian VV, et al. A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100. Virology 159: 191-192, 1987. PubMed: 3037780
|
